Viewing Study NCT00048295


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-01-01 @ 3:40 PM
Study NCT ID: NCT00048295
Status: COMPLETED
Last Update Posted: 2022-08-15
First Post: 2002-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module